Pharmaceutical discount contracts from 01.05.2025 for various active substances within the framework of an Open-House procedure

AOK NordWest - Die Gesundheitskasse·Dortmund, Germany·Deadline Feb 22, 2027 · 178 days left·Open·Supplies

Inscrivez-vous pour sauvegarder Open documents

Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.05.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

50/100

Score d'opportunité

Needs reviewLow complexity

SuppliesOpen

Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

The buyer may award exclusive discount contracts during the term, causing the Open-House contracts to be suspended. The...

No contract value or volume is published; potential revenue is unknown.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Supplies contract
1 lot
Duration until Apr 2027
Supply of pharmaceutical products for the listed active substances
Conclusion of discount agreements under §130a Abs. 8 SGB V

Afficher le résumé complet

Open-House procedure for pharmaceutical discount contracts (Rabattverträge) under §130a Abs. 8 SGB V for six active substances, offered by AOK NordWest. The procedure is not a public procurement under EU law; any eligible pharmaceutical entrepreneur may join at any time. Contracts run for max 24 months starting 01.05.2025. No estimated value disclosed. Non-exclusive, but the buyer may later award exclusive contracts that suspend these agreements.

Risques

The buyer may award exclusive discount contracts during the term, causing the Open-House contracts to be suspended. The...

No contract value or volume is published; potential revenue is unknown.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined in §4 Abs. 18 AMG for the offered medicinal products

Eligibility

Eligibility must persist for the entire contract duration

Administrative

Uniform contract terms apply; no individual negotiations

Acheteur

Nom

AOK NordWest - Die Gesundheitskasse

Localisation

Dortmund, DEU

[email protected]

Site web

www.aok.de

Identifiant

DE124159739

Activité

Health

Lots (1)

LOT-0001

Pharmaceutical discount contracts from 01.05.2025 for various active substances within the framework of an Open-House procedure

Uniform terms for all interested pharmaceutical entrepreneurs covering active substances: Aclidiniumbromide & Formoterol (R03AL05), Carglumic acid (A16AA05), Dabigatran (B01AE07), Mepolizumab (R03DX09), Opipramol (N06AA05), Pegfilgrastim (L03AA13). Earliest start 01.05.2025, duration max 24 months.

SuppliesEU fundedElectronic submission

Localisation

Hagen, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Feb 22, 2027

Détails de la procédure

Date de publication: 03 Mar 2025
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 141923-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3